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SUMMARY
Screening for critical congenital heart defects in newborn
babies can aid in early recognition, with the prospect of
improved outcome. However, as this universal newborn
screening is implemented, there will be an increasing
number of false-positive results. In order to avoid
multiple investigations and uncertainty, an haemoglobin
(Hb) variant must be included in the differential
diagnosis in otherwise well newborns with low oxygen
saturation by pulse oximetry. We describe a novel fetal
Hb variant (heterozygous γ-globin gene (HBG1)
mutation in exon 2 c.202G>A (p.Val68Met)) identiﬁed
in a newborn with positive pulse oximetry screening for
congenital heart disease.
BACKGROUND
Pulse oximetry is a non-invasive and widely used
photometric method to estimate a patient’s arterial
oxygen saturation.1 Oxy and deoxy haemoglobin
(Hb) show unique absorbance at 660 and 940 nm,
respectively, and the pulse oximeter determines
oxygen saturation by measuring a ratio of pulsatile
light transmission through a cutaneous vascular bed
at the two wavelengths.2 This instrument is of great
importance in paediatrics as it can detect disorders
in oxygen uptake and distribution.3 Despite the
current widespread use of pulse oximetry we must
be aware of its limitations. Measurement anomalies
can occur due to motion artefacts, nail varnish,
reduced local perfusion, venous pulsation, optical
and electrical interfering radiation, Hb variants and
anatomical and/or histological conditions.2
Sometimes, patients are found unexpectedly to
have low oxygen saturation by pulse oximetry
(SpO2). They may undergo extensive cardiopul-
monary investigations since low oxygen saturation
is found in many malformations and diseases of the
respiratory tract, functional breathing disorders and
in congenital heart defects.4 5 However, when diag-
nostic cardiopulmonary ﬁndings remain ambiguous,
arterial blood gas measurements (PaO2 and SaO2)
are normal and SpO2 readings are low, an Hb
variant should be considered in the differential
diagnosis.6–12
Hb is a tetrameric protein composed of two
α-globin chains and two non-α (β, γ, δ)-globin
chains that combine with four haeme groups. In the
adult, normal Hb mainly consists of HbA (α2β2),
with a small fraction of HbA2 (α2δ2) and an even
smaller fraction of HbF (α2γ2). In newborns, the
largest fraction is composed by HbF and the change-
over to HbA takes place over the ﬁrst 6 months of
age. Genetic alterations that conduct to synthesis of
Hb with abnormal structure (Hb variant) or to
reduced synthesis of globin chains (Thalassaemia)
are known as haemoglobinopathies.10 Included in
1641 known haemoglobinopathies, of which 131
are of fetal origin, there are α-globin, β-globin and
γ-globin variants that affect oxygen binding afﬁn-
ity.13 Mutations in γ-globin genes (HBG1 or HBG2)
can cause neonatal symptoms that are transient and
will disappear in the ﬁrst months of life. Mutations
in the α-globin gene (HbA1 or HBA2) can cause
newborn cyanosis that will persist throughout life.
Mutations in the β-globin gene (HBB) will only
become clinically signiﬁcant months after birth.14
Hb variants known to have low SpO2 measurements
are listed in ﬁgure 1.8
The use of pulse oximetry in universal screening
for cyanotic congenital heart defects was recently
recommended at a national and international
level.15–17 As it is implemented and becomes a
nursery routine, an increasing number of asymptom-
atic patients with unexpectedly low SpO2 will prob-
ably be uncovered. In order to reduce patients’
distress and parent’s anxiety, and to avoid inappro-
priate investigations, an Hb variant must be included
in the differential diagnosis.7 These patients’ diag-
nostic work up should include an arterial blood gas
(ABG) sampling, with analysis by CO-oximetry, to
document the PaO2 status and rule out the presence
of signiﬁcant amounts of methe/carboxyhaemoglo-
bin (MetHb/COHb). If PaO2 is normal, an Hb
assessment should be made, including electrophor-
esis, high-performance liquid chromatography and
isoelectric focusing. In the presence of an abnormal
Hb variant, DNA sequence analysis is necessary to
identify and characterise the mutation.8 18 19
This report aims to describe an unknown Hb
variant (mutation in HBG1 exon 2 c.202G>A
(p.Val68Met)) in order to alert physicians to the
novelty of this subject and its true clinical daily
practice implications.
CASE PRESENTATION
We report a case of a late preterm newborn girl,
with no relevant family history, delivered by caesar-
ean section at 36 weeks because of fetal distress. At
birth, the Apgar scores were 9 and 10 at 1 and
5 min, respectively. The baby weighed 2.350 kg,
was clinically well and the physical examination
was unremarkable.
INVESTIGATIONS AND DIFFERENTIAL
DIAGNOSIS
On the second day of life, pulse oximetry screening
for congenital heart disease detected a persistent
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SpO2 of 83–90%. Cardiovascular examination, echocardiog-
raphy and chest radiography were normal. CT angiography
ruled out anomalous pulmonary venous return and arterioven-
ous malformations. Septic and metabolic screenings were nega-
tive. Haematological parameters were within the reference
intervals, with normal results on standard Hb electrophoresis
and methaemoglobin level. Oxygen therapy was started, with
poor response.
By day 11, the baby was transferred to the paediatric intensive
care unit, for monitoring and further evaluation. Pulse oximetry
revealed a low SpO2 despite the absence of arterial hypoxia in
the ABG (PaO2 94.8 mm Hg and SaO2 97.4%, with SpO2 88%)
and a normal hyperoxia test (PaO2 507 mm Hg and SaO2 99%,
with max SpO2 of 93%). ABG revealed a mild lactic acidosis
with lactate 2.3–3.6 mmol/L. She was discharged by day 12
with a normal physical examination and a sustained low SpO2,
and referred to the haematology outpatient clinic.
Further investigations revealed an unknown Hb F variant
(Val68Met—26.9%) on high-performance liquid chromatog-
raphy (HPLC). With this diagnostic possibility, PCR sequence
analysis of the patient’s haemoglobin genes was performed and
a novel heterozygous γ-globin gene (HBG1) mutation in exon 2
c.202G>A was identiﬁed. This was the ﬁrst description of the
Val68Met mutation at γ1-globin chains but the same variant,
named Hb Tom River, was already described in the γ2-globin
chains in a new born with cyanosis.14
OUTCOME AND FOLLOW-UP
The baby’s clinical course was unremarkable and by 4 months
of age, her SpO2 was consistently higher than 95%. At the time
of writing this paper, she is healthy.
DISCUSSION
Screening for cyanotic congenital heart defects through pulse
oximetry allows early recognition and referral of potentially life-
threatening conditions to specialised centres. Nonetheless, its
widespread use will probably lead to false-positive results that
can result in extensive investigations, and represent a burden to
families and healthcare systems.
With the case presented here, we wish to alert those con-
cerned to an emerging condition that can mimic a cyanotic
heart defect. Hb variants can have different readings by pulse
oximetry. In this case, this previously unknown Hb variant was
not detected as oxyhaemoglobin by the pulse oximeter,
although the SaO2 measured in blood gas analysis by
CO-oximetry was normal. At ﬁrst, we thought that this was just
a technical problem related to limitations in pulse oximetry
accuracy and that the patient did not have a problem with
oxygen transport or delivery to the tissues. However, there was
a sign that this could not be so simple. Lactate was mildly ele-
vated in all blood gas analyses. This suggests that the later iden-
tiﬁed Hb variant has a high afﬁnity to oxygen and compromises
oxygen delivery to tissues, resulting in tissue hypoxia.
It is quite ironic that the false reading of low SpO2 was actually
reﬂecting a deﬁcient oxygen delivery, not detectable by blood gas
analysis and the gold standard CO-oximetry. This is exactly the
opposite of what happens in more common conditions such as
carbon monoxide intoxication or methaemoglobinaemia, where
a falsely normal SpO2 hides the presence of dyshaemoglobins
(COHb and MetHb) only detectable by CO-oximetry.
Another interesting point is that the defect was in the γ-globin
gene, meaning that it only affects fetal haemoglobin. This
explains SpO2 normalisation by 4 months of age when Hb F pro-
duction decreases. If pulse oximetry had not been performed as
part of the congenital heart disease screening programme, this
condition would probably never have been diagnosed. This raises
the question of how many similar cases will appear with the
widespread use of these screening programmes.
Judicious use of ancillary tests is advised in the investigation
of these cases. Simple and inexpensive tests such as blood gas
analysis and the hyperoxia test would have excluded a right to
left shunt, avoiding the need for CTangiography.
We hope that the case described here will alert physicians to
this new problem and help others when faced with an unex-
plained low SpO2 measurement in a newborn or even in an
older patient.
Figure 1 Haemoglobin (Hb) anomalies with low SpO2 measurements.
Hb variants clinically signiﬁcant in newborns appear in italics.
Reprinted from Zur et al.8 Reprinted with permission.
Learning points
▸ We describe a novel haemoglobin variant that can mimic
cyanotic congenital heart disease.
▸ Screening for critical congenital heart defects in newborns
can aid in early recognition of potentially life-threatening
conditions.
▸ Haemoglobin variants must be included in the differential
diagnosis in otherwise well newborns with an unexplained
low SpO2 measurement, in order to avoid multiple
investigations, and a burden to families and healthcare
systems.
2 Abecasis F, et al. BMJ Case Rep 2016. doi:10.1136/bcr-2015-213615
Reminder of important clinical lesson
Competing interests None declared.
Patient consent Obtained.
Provenance and peer review Not commissioned; externally peer reviewed.
REFERENCES
1 Neff TA. Routine oximetry. A ﬁfth vital sign? Chest 1988;94:227.
2 Jubran A. Pulse oximetry. Intensive Care Med 2004;30:2017–20.
3 Fouzas S, Priftis KN, Anthracopulos MB. Pulse oximetry in pediatric practice.
Pediatrics 2011;128:740–52.
4 Bowes WA, Corke BC, Hulka J. Pulse oximetrie: a review of the theory, accuracy,
and clinical applications. Obstet Gynecol 1989;74:541–6.
5 de-Wahl Granelli A, Wennergren M, Sandberg K et al. Impact of pulse oximetry
screening on the detection of duct dependent congenital heart disease: a Swedish
prospective screening study in 39821 newborns. BMJ 2009;338:a3037.
6 Hladik A, Lynshue K. Dyshemoglobinemias and pulse oximetry: a therapeutic
challenge. J Pediatr Hematol Oncol 2008;30:850–2.
7 Verhovsek M, Henderson MP, Cox G, et al. Unexpectedly low pulse oximetry
measurements associated with variant hemoglobins: a systematic review. Am J
Hematol 2010;85:882–5.
8 Zur B, Bagci S, Ludwig M, et al. Oxygen saturation in pulse oximetry in hemoglobin
anomalies. Klin Padiatr 2012;224:259–65.
9 Deyell R, Jackson S, Spier S, et al. Low oxygen saturation by pulse oximetry may be
associated with a low oxygen afﬁnity hemoglobin variant, hemoglobin Titusville.
J Pediatr Hematol Oncol 2006;28:100–2.
10 Zur B, Hornung A, Breuer J, et al. A novel hemoglobin, Bonn, causes falsely
decreased oxygen saturation measurements in pulse oximetry. Clin Chem
2008;54:594–6.
11 Mounts J, Clingenpeel J, White N, et al. Apparent desaturation on pulse oximetry
because of hemoglobinopathy. Pediatr Emerg Care 2010;26:748–9.
12 Sarikonda KV, Ribeiro RS, Herrick JL, et al. Hemoglobin lansing: a novel hemoglobin
variant causing falsely decreased oxygen saturation by pulse oximetry. Am J
Hematol 2009;84:541.
13 Patrinos GP, Giardine B, Riemer C, et al. Improvements in the HbVar database of
human hemoglobin variants and thalassemia mutations for population and
sequence variation studies. Nucleic Acids Res 2004;32(Database issue):D537–41.
http://globin.cse.psu.edu/hbvar/menu.html http://dx.doi.org/10.1093/nar/gkh006
14 Crowley MA, Mollan TL, Abdulmalik OY et al. A hemoglobin variant associated with
neonatal cyanosis and anemia. N Engl J Med 2011;364:1837–43.
15 Advisory Committee on Heritable Disorders in Newborns and Children. Letter to the
Secretary of U.S. Department of Health and Human Services. 15 October 2010.
http://www.hrsa.gov/heritabledisorderscommittee/correspondence/
October15th2010letter.htm
16 Hoffman JI. It is time for routine neonatal screening by pulse oximetry. Neonatology
2011;99:1–9.
17 Morais S, Mimoso G. Oximetria de pulso no diagnóstico de cardiopatia congénita.
Sugestões para a implementação de uma estratégia de rastreio. Acta Pediatr Port
2013;44:343–7.
18 Lafferty JD, Waye JS, Chui DHK, et al. Good practice guidelines for laboratory
investigation of hemoglobinopathies. Lab Hematol 2003;9:237–45.
19 Spinola AIF, Guilherme RF, Bento C, et al. Cianose central neonatal: nem sempre
cardíaca, nem sempre pulmonar. Acta Pediatr Port 2014;45:227–30.
Copyright 2016 BMJ Publishing Group. All rights reserved. For permission to reuse any of this content visit
http://group.bmj.com/group/rights-licensing/permissions.
BMJ Case Report Fellows may re-use this article for personal use and teaching without any further permission.
Become a Fellow of BMJ Case Reports today and you can:
▸ Submit as many cases as you like
▸ Enjoy fast sympathetic peer review and rapid publication of accepted articles
▸ Access all the published articles
▸ Re-use any of the published material for personal use and teaching without further permission
For information on Institutional Fellowships contact consortiasales@bmjgroup.com
Visit casereports.bmj.com for more articles like this and to become a Fellow
Abecasis F, et al. BMJ Case Rep 2016. doi:10.1136/bcr-2015-213615 3
Reminder of important clinical lesson
